Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register
Objectives To investigate the impact of disease activity and treatment with disease-modifying antirheumatic drugs (DMARDs) on all-cause mortality in patients with rheumatoid arthritis and prevalent interstitial lung disease (RA-ILD).Methods Patients with RA-ILD were selected from the biologics regis...
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
BMJ Publishing Group
2024-05-01
|
| سلاسل: | RMD Open |
| الوصول للمادة أونلاين: | https://rmdopen.bmj.com/content/10/2/e003789.full |